enteral nutrition, feeding tube, head and neck cancer, intensity-modulated radiotherapy (IMRT), tox
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
https://plus.google.com/commun....ities/11546213005465
,
,https://plus.google.com/u/0/+A....lexandrosGSfakianaki
,
https://www.youtube.com/channe....l/UCQH21WX8Qn5YSTKrl
,
https://www.youtube.com/channe....l/UCTREJHxB6yt4Gaqs4
,
https://twitter.com/g_orl?lang=el,
https://www.instagram.com/alexandrossfakianakis/,
Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer.
Science.gov (United States)
Anderson, Nigel J; Jackson, James E; Smith, Jennifer G; Wada, Morikatsu; Schneider, Michal; Poulsen, Michael; Rolfo, Maureen; Fahandej, Maziar; Gan, Hui; Joon, Daryl Lim; Khoo, Vincent
2018-05-13 PubMed
DOI: 10.1002/hed.25316 ISSN: 1043-3074
Keywords: enteral nutrition, feeding tube, head and neck cancer, intensity-modulated radiotherapy (IMRT), toxicity
The purpose of this study was to establish a risk stratification model for feeding tube use in patients who undergo intensity-modulated radiotherapy (IMRT) for head and neck cancers. One hundred thirty-nine patients treated with definitive IMRT (+/- concurrent chemotherapy) for head and neck mucosal cancers were included in this study. Patients were recommended a prophylactic feeding tube and followed up by a dietician for at least 8 weeks postradiotherapy (post-RT). Potential prognostic factors were analyzed for risk and duration of feeding tube use for at least 25% of dietary requirements. Many variables had significant effects on risk and/or duration of feeding tube use in univariate analyses. Subsequent multivariable analysis showed that T classification ≥3 and level 2 lymphadenopathy were the best independent significant predictors of higher risk and duration of feeding tube use, respectively, in oral cavity, pharyngeal, and supraglottic primaries. In patients treated with definitive IMRT, T classification ≥3 and level 2 lymphadenopathy can potentially stratify patients into 4 risk groups for developing severe dysphagia requiring feeding tube use. © 2018 Wiley Periodicals, Inc.
-
Category
![Actinic Keratosis Treatment and Cancer Potential - Eyelid, Face, and Neck [Dermatology Course 32/60]](https://i.ytimg.com/vi/ffcHWDpKZqQ/maxresdefault.jpg)
No comments found